HVG-14346-61990 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-21
Dose 1 — Pfizer-BioNTech
2022-07-23
Registered in v-safe
2022-07-23
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Poor · Fever · Sleepiness, Irritability/crying · Be unable to work or attend school, Be unable to do your normal daily activities

Under 3 check-in
2022-07-24
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Covid at home test Binax positive

MedDRA releases: 2024-11 · check-in free text available
2022-07-25
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Covid rapid test positive yesterday

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-21	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-07-24

Systemic reaction (other): Covid at home test Binax positive

2022-07-25

Systemic reaction (other): Covid rapid test positive yesterday

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	SARS-CoV-2 test positive	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release